Benzinga

Benzinga

Benzinga

dimanche, septembre 06

Bioage Labs Inc

BIOANASDAQ
Trade with Public
Trade with Public
$9.59
0.090.95%
À la clôture: Sep 4, 5:00 PM EST
$9.55
-0.04-0.42%
Après les heures: Sep 4, 6:14 PM EST
AperçuActualitésPrévisions de résultatsÉvénementsObjectifs de coursDonnées financièresSentimentActionnariatComparerOptionsRapport sur les stocks

Bioage Labs Financials

Bioage Labs (BIOA) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Bioage Labs Q2 EPS $(0.58) Beats $(0.60) Estimate, Sales $2.451M Beat $1.920M Estimate

Bioage Labs (NASDAQ:BIOA) reported quarterly losses of $(0.58) per share which beat the analyst consensus estimate of $(0.60) by 3.33 percent. This is a 3.33 percent increase over losses of $(0.60) per share from the
Benzinga Newsdesk

PRO
Bioage Labs Q1 EPS $(0.52) Beats $(0.64) Estimate, Sales $2.772M Beat $1.083M Estimate

Bioage Labs (NASDAQ:BIOA) reported quarterly losses of $(0.52) per share which beat the analyst consensus estimate of $(0.64) by 18.75 percent. This is a 44.44 percent decrease over losses of $(0.36) per share from the
Benzinga Newsdesk

PRO
Bioage Labs Q4 EPS $(0.72) Beats $(0.73) Estimate, Sales $3.078M Beat $1.915M Estimate

Bioage Labs (NASDAQ:BIOA) reported quarterly losses of $(0.72) per share which beat the analyst consensus estimate of $(0.73) by 1.37 percent. This is a 22.03 percent decrease over losses of $(0.59) per share from the
Benzinga Newsdesk

PRO
Bioage Labs Q3 EPS $(0.56) Beats $(0.58) Estimate, Sales $2.054M

Bioage Labs (NASDAQ:BIOA) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.58) by 3.45 percent. This is a 91.64 percent increase over losses of $(6.70) per share from the
Benzinga Newsdesk

PRO
Bioage Labs Q2 EPS $(0.60) Misses $(0.45) Estimate

Bioage Labs (NASDAQ:BIOA) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0.45) by 33.33 percent.
Benzinga Newsdesk

PRO
Bioage Labs Q1 EPS $(0.36) Beats $(0.53) Estimate, Sales $1.45M

Bioage Labs (NASDAQ:BIOA) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.53) by 32.08 percent. This is a 95.36 percent increase over losses of $(7.76) per share from the
Benzinga Newsdesk

Données et API: API Benzinga · API d'actualités boursières · API de notations d'analystes · API de logo d'entreprise

Benzinga

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

© 2026 Benzinga | All Rights Reserved